The article discusses the potential impact of artificial intelligence (AI) on healthcare deals and venture capital investments by 2024. It highlights that AI is expected to play a significant role in various aspects of healthcare, including drug discovery, clinical trials, and patient care. The key points and predictions include: 1) AI-powered drug discovery will accelerate, leading to more efficient and cost-effective development processes. 2) Clinical trials will leverage AI for patient recruitment, data analysis, and risk assessment, improving trial success rates. 3) AI-enabled diagnostic tools and virtual assistants will enhance patient care and disease management. 4) Venture capital firms will increase investments in AI-driven healthcare startups, with a focus on areas like precision medicine and predictive analytics. 5) Partnerships between tech giants and healthcare companies will grow, combining AI expertise with medical knowledge. The article concludes that AI has the potential to revolutionize healthcare by 2024, driving innovation, reducing costs, and improving patient outcomes.
Source: https://www.businessinsider.com/healthcare-deals-venture-capital-predictions-ai-2024-12